STEMCHYMAL Trademark

Trademark Overview

On Friday, March 24, 2017, a trademark application was filed for STEMCHYMAL with the United States Patent and Trademark Office. The USPTO has given the STEMCHYMAL trademark a serial number of 87384683. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, October 11, 2024. This trademark is owned by STEMINENT BIOTHERAPEUTICS INC.. The STEMCHYMAL trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical purposes for the treatment of Spinocerebellar ataxia, Neuron Diseases, [ Diabetes Mellitus, Acute Liver Failure and Knee Osteoarthritis; biological preparations for veterinary purpose for treating skin disorders; biological tissue cultures for medical purposes;] biological tissue cultures for veterinary purposes; medicines for human purposes for the treatment of Spinocerebellar ataxia, Neuron Diseases, [ Diabetes Mellitus, Acute Liver Failure and Knee Osteoarthritis; medicines for veterinary purposes for treating allergies; ] stem cells for medical purposes [ ; stem cells for veterinary purposes ]
stemchymal

General Information

Serial Number87384683
Word MarkSTEMCHYMAL
Filing DateFriday, March 24, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, October 11, 2024
Registration Number5538260
Registration DateTuesday, August 14, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements

Goods and ServicesBiological preparations for medical purposes for the treatment of Spinocerebellar ataxia, Neuron Diseases, [ Diabetes Mellitus, Acute Liver Failure and Knee Osteoarthritis; biological preparations for veterinary purpose for treating skin disorders; biological tissue cultures for medical purposes;] biological tissue cultures for veterinary purposes; medicines for human purposes for the treatment of Spinocerebellar ataxia, Neuron Diseases, [ Diabetes Mellitus, Acute Liver Failure and Knee Osteoarthritis; medicines for veterinary purposes for treating allergies; ] stem cells for medical purposes [ ; stem cells for veterinary purposes ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 29, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTEMINENT BIOTHERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei City 11492
TW
Party NameSTEMINENT BIOTHERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 114
TW
Party NameSTEMINENT BIOTHERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 114
TW

Trademark Events

Event DateEvent Description
Monday, June 26, 2017PRIORITY ACTION WRITTEN
Tuesday, March 28, 2017NEW APPLICATION ENTERED
Wednesday, March 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 17, 2017ASSIGNED TO EXAMINER
Monday, June 26, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, June 26, 2017PRIORITY ACTION E-MAILED
Sunday, October 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2017NON-FINAL ACTION WRITTEN
Thursday, October 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017NON-FINAL ACTION E-MAILED
Monday, November 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 10, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, December 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 5, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 5, 2018NOTICE OF ALLOWANCE CANCELLED
Tuesday, July 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, December 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 12, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 10, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 11, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 11, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

stemchymal purposes biological veterinary medical treating knee osteoarthritis medicines cells stem